Open access · CC-BY
via OpenAlex
Cell-Autonomous Progeroid Changes in Conditional Mouse Models for Repair Endonuclease XPG Deficiency
Sander Barnhoorn, Lieneke M. Uittenboogaard, Dick Jaarsma, Wilbert P. Vermeij, Maria Tresini, Michael Weymaere, Hervé Menoni, Renata M. C. Brandt, Monique C. de Waard, Sander M. Botter, Altaf H. Sarker, Nicolaas G.J. Jaspers, Gijsbertus T. J. van der Horst, Priscilla K. Cooper, Jan H.J. Hoeijmakers
PLoS Genetics · 2014 · ▲ 64 citations
Abstract
As part of the Nucleotide Excision Repair (NER) process, the endonuclease XPG is involved in repair of helix-distorting DNA lesions, but the protein has also been implicated in several other DNA repair systems, complicating genotype-phenotype relationship in XPG patients. Defects in XPG can cause either the cancer-prone condition xeroderma pigmentosum (XP) alone, or XP combined with the severe neurodevelopmental disorder Cockayne Syndrome (CS), or the infantile lethal cerebro-oculo-facio-skeletal (COFS) syndrome, characterized by dramatic growth failure, progressive neurodevelopmental abnormalities and greatly reduced life expectancy. Here, we present a novel (conditional) Xpg-/- mouse model which -in a C57BL6/FVB F1 hybrid genetic background- displays many progeroid features, including cessation of growth, loss of subcutaneous fat, kyphosis, osteoporosis, retinal photoreceptor loss, liver aging, extensive neurodegeneration, and a short lifespan of 4-5 months. We show that deletion of XPG specifically in the liver reproduces the progeroid features in the liver, yet abolishes the effect on growth or lifespan. In addition, specific XPG deletion in neurons and glia of the forebrain creates a progressive neurodegenerative phenotype that shows many characteristics of human XPG deficiency. Our findings therefore exclude that both the liver as well as the neurological phenotype are a secondary consequence of derailment in other cell types, organs or tissues (e.g. vascular abnormalities) and support a cell-autonomous origin caused by the DNA repair defect itself. In addition they allow the dissection of the complex aging process in tissue- and cell-type-specific components. Moreover, our data highlight the critical importance of genetic background in mouse aging studies, establish the Xpg-/- mouse as a valid model for the severe form of human XPG patients and segmental accelerated aging, and strengthen the link between DNA damage and aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pgen.1004686
- Canonical
- link ↗
- Fetched
- 2026-07-09 MST
Cite this
APA
Barnhoorn, S., Uittenboogaard, L.M., Jaarsma, D., Vermeij, W.P., Tresini, M., Weymaere, M., Menoni, H., Brandt, R.M.C., Waard, M.C.D., Botter, S.M., Sarker, A.H., Jaspers, N.G., Horst, G.T.J.V.D., Cooper, P.K., Hoeijmakers, J.H., & Pluijm, I.V.D. (2014). Cell-Autonomous Progeroid Changes in Conditional Mouse Models for Repair Endonuclease XPG Deficiency. <em>PLoS Genetics</em>. https://doi.org/10.1371/journal.pgen.1004686
Vancouver
Barnhoorn S, Uittenboogaard LM, Jaarsma D, Vermeij WP, Tresini M, Weymaere M, et al. Cell-Autonomous Progeroid Changes in Conditional Mouse Models for Repair Endonuclease XPG Deficiency. PLoS Genetics. 2014. doi:10.1371/journal.pgen.1004686.
BibTeX
@article{sander2014CellAu,
title = {Cell-Autonomous Progeroid Changes in Conditional Mouse Models for Repair Endonuclease XPG Deficiency},
author = {Sander Barnhoorn and Lieneke M. Uittenboogaard and Dick Jaarsma and Wilbert P. Vermeij and Maria Tresini and Michael Weymaere and Hervé Menoni and Renata M. C. Brandt and Monique C. de Waard and Sander M. Botter and Altaf H. Sarker and Nicolaas G.J. Jaspers and Gijsbertus T. J. van der Horst and Priscilla K. Cooper and Jan H.J. Hoeijmakers and Ingrid van der Pluijm},
journal = {PLoS Genetics},
year = {2014},
doi = {10.1371/journal.pgen.1004686},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Neuroscience 2010
Open access · CC-BY
The Dopaminergic System in the Aging Brain of Drosophila
Journal of Neurochemistry 2010
Open access · OA
Nature and cause of mitochondrial dysfunction in Huntington’s disease: focusing on huntingtin and the striatum
Acta Scientific Pharmaceutical Sciences 2024
Open access · OA
A Research on Long-Term Effects and Cellular Mechanisms of Resveratrol, Fisetin, and Senolytics on Human Healthspan and Lifespan: Insights from Animal Model Studies
Maturitas 2024
Citation only
Healthy aging among centenarians and near-centenarians: Findings from the Georgia Centenarian Study.
Frontiers in Molecular Neuroscience 2018
Open access · CC-BY
Studying Huntington’s Disease in Yeast: From Mechanisms to Pharmacological Approaches
bioRxiv (Cold Spring Harbor Laboratory) 2023
Preprint · OA